Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0163399001
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Marketed | 02525267 | UCB CANADA INC | BIMZELX | Human | Yes | Schedule D | 1 | BIMEKIZUMAB | 160 MG / ML |
Marketed | 02525267 | UCB CANADA INC | BIMZELX | Human | Yes | Prescription | 1 | BIMEKIZUMAB | 160 MG / ML |
Marketed | 02525275 | UCB CANADA INC | BIMZELX | Human | Yes | Schedule D | 1 | BIMEKIZUMAB | 160 MG / ML |
Marketed | 02525275 | UCB CANADA INC | BIMZELX | Human | Yes | Prescription | 1 | BIMEKIZUMAB | 160 MG / ML |
Approved | 02553619 | UCB CANADA INC | BIMZELX | Human | Yes | Prescription | 1 | BIMEKIZUMAB | 320 MG / 2 ML |
Approved | 02553619 | UCB CANADA INC | BIMZELX | Human | Yes | Schedule D | 1 | BIMEKIZUMAB | 320 MG / 2 ML |
Approved | 02553627 | UCB CANADA INC | BIMZELX | Human | Yes | Schedule D | 1 | BIMEKIZUMAB | 320 MG / 2 ML |
Approved | 02553627 | UCB CANADA INC | BIMZELX | Human | Yes | Prescription | 1 | BIMEKIZUMAB | 320 MG / 2 ML |
Application information
Related information
Contact us
Version 4.0.3